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MYCOPLASMAS AS PATHOGENS
This paper concerns several animal models for study of pathogenic mecha-
nisms in mycoplasma infection. Although these will seem remote from the
general topic of this symposium, it is conceivable that some of the mecha-
nisms may have implications for chronic pulmonary disease. Mycoplasmas
are known to be causative agents in acute and chronic pulmonary infections
in several species of domestic animals. One species, M. pneumoniae, is now
established as the cause of primary atypical pneumonia in man, and the
way may now be open for investigation of the role of mycoplasmas in other
varieties of lung disease.
Toxicity of mycoplasmas
There are now known to be four unrelated species of mycoplasma that
cause death by virtue of a toxic property of the living organisms, in a
manner reminiscent of the toxicity of certain viruses.
The first two of these, which cause toxic symptoms and death in a gen-
erally similar manner, are M. arthritidis, the causative agent of acute and
chronic arthritis in rats and mice, and M. pulmonis, a presumed cause of
acute and chronic lung disease in rodents.'
When cultures or washed suspensions of live organisms of either species
are inoculated by vein, the animals become prostrated, usually after a latent
interval of three to four hours. They usually die within a period of 12 hours
or less; with very large doses (101-1011 organisms), death can be brought
about within as short a time as one hour after inoculation.
The organisms are required to be alive for this to work. Animals can be
partially protected by pretreatment with tetracycline or gold thiomalate,
suggesting that the organisms may be elaborating a toxic material after
being injected. Extracts of sonically disintegrated mycoplasmas are with-
out toxicity, nor can any exotoxin be demonstrated in culture filtrates.
The toxicity of these two strains has a high degree of species specificity;
the only laboratory animals thus far shown to be affected by either M.
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arthritidis or M. pulmonis are rats and mice. Chick embryos, rabbits,
hamsters, and guinea pigs are completely resistant.
Pathologic studies give no clue as to the mechanism of death.
A third toxic species is the S-6 strain of Mycoplasma gallisepticum.'
This organism has long been known in poultry circles to be the cause of
outbreaks of scattered, sporadic but relatively uncommon outbreaks of
encephalopathy in association with the common respiratory disease of
turkeys. The strain has been shown to be capable of producing periarteritis
nodosa, affecting selectively the arteries of the central nervous system of
the turkey poult.
When large doses of this strain (109 or more colony-forming units) are
given by vein to turkey poults, the animals become neurologically ill after
a latent interval as short as one hour. They exhibit ataxia, staggering,
weakness, and finally convulsive rolling movements. They resemble, to a
remarkable degree, mice with rolling disease. Death occurs usually within
less than two hours after inoculation.
We have been unable to demonstrate any soluble toxin for this organism.
However, there is reason to suspect that the toxicity involves active work
on the part of the organism after it is injected. As in the case of the rodent
strains of toxic mycoplasma, turkeys can be completely protected against
neurotoxicity by treatment beforehand with tetracycline or gold thiomalate.
Killed organisms are without toxic effect.
Animals surviving the acute, overwhelming neurotoxicity of this organ-
ism go on to develop periarteritis nodosa in the arteries of the brain. These
lesions usually become evident within two days after intravenous injection.
The neurotoxic property of M. gallisepticum is separate from and can
be dissociated from the capacity of this organism to produce periarteritis
nodosa. When turkeys are infected with low doses of M. gallisepticum, they
may exhibit no clinical evidences of neurologic disease whatever, but they
do develop a chronic, granulomatous form of polyarteritis of the cerebral
vessels. Since this lesion is still progressing as late as two months after
infection, it is likely that live organisms are involved in its pathogenesis.
It is not easy to explain the pathogenesis of arteritis on the basis of a
toxin; nevertheless, this seems the likeliest mechanism at the present time.
Conceivably, the slow and steady elaboration of toxin may cause arterial
necrosis if the organisms survive at a distant site (as in the paranasal
sinuses) for long periods of time. The problem has important implications
for the problem of polyarteritis in general.
The fourth mycoplasma with toxic properties is M. neurolyticum, the
cause of "rolling disease" in mice.` This organism elaborates an exotoxin,
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an extremely thermolabile protein which appears to exert its effect by an
action on membrane constituents of the central nervous system. By ultra-
structural studies, its effects appear to be primarily the opening up of the
system of astrocytes and their filamentous connections to large amounts of
fluid inflow from the blood, so that the animals develop engorged foci of
spongiform encephalopathy. By electron microscopy, the lesions are seen
to consist of greatly engorged astrocytes.'
By virtue of this property of the toxin, the blood brain barrier is abro-
gated in animals with rolling disease, as measured by trypan blue staining
and by the uptake of radioactive glycine.
The exotoxin has a high degree of affinity for receptors in the brain;
irreversible binding, with complete resistance to the protective action of
specific antibody, occurs within three minutes after intravenous injection
in mice. Inactivation of the toxin can be brought about by exposure to a
suspension of the membrane fraction of brain homogenates; the inactivating
component of brain is probably a ganglioside.'
Affinity of mycoplasmas for cell surfaces
It has been observed repeatedly that mycoplasmas tend to aggregate in
more or less dense masses on the surfaces of infected cells, whether in the
course of natural infections of animals or when they occur as contaminants
in tissue cultures. We have investigated the phenomenon, using erythro-
cytes, lymphocytes and various tissue culture preparations.
M. gallisepticum attaches rapidly and firmly to the surface of erythro-
cytes, causing hemagglutination. Attachment involves erythrocyte receptors
containing sialic acid.' Once attached, the mycoplasmas produce sufficient
amounts of peroxide to convert hemoglobin to methemoglobin and, fre-
quently, to cause lysis of the erythrocytes.7
In experiments with tissue cultures, cells were exposed on glass slides
to suspensions of washed mycoplasmas, for varying periods of time, usually
20 to 30 minutes, and rocked back and forth in tubes at 370 C. They were
then washed several times and stained with Giemsa. Washing was suffi-
cient to remove all unattached mycoplasmas. The attached mycoplasmas
fixed to the surface of the cells could not be removed by any amount of
additional washing.
Attachment to the surface of tissue culture cells was found to be tem-
perature-dependent, occurring most rapidly at 370 C. As with erythrocytes,
sialic acid receptors appear to be involved. Trypsinization of the mycoplas-
mas removes their capacity to attach, although this is restored when the
organisms are incubated for several hours in the presence of glucose.
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The same degree of affinity between mycoplasmas and the cell surface
exists for lymphocytes.'89 A convenient way of measuring and following
the attachment of mycoplasmas was found to be by agglutination of the
lymphocytes, which occurs within a few minutes after exposure to myco-
plasmas. Lattice formation between the aggregates of mycoplasmas at-
tached to the lymphocytes appeared to be the basis for agglutination.
Agglutination of lymphocytes was prevented by sialic inhibitors and
failed to occur when the mycoplasmas were themselves treated with trypsin.l
With these observations at hand, an artificial but interesting model could
be constructed for the aggregation of lymphocytes at the surfaces of tissue
culture cells. A suspension of washed mycoplasmas was added to a sheet
of mouse L cells, allowed to become fixed in place, and washed; then a
suspension of normal mouse lymphocytes was added. The lymphocytes
remained in contact with the "labelled" L cells for one hour at 37° C., and
the preparation was washed again. Each tissue culture cell was found to be
surrounded by a rosette of firmly attached lymphocytes. Varying concen-
trations of cell-aggregated lymphocytes could be brought about by varying
the number of mycoplasmas attached to the surface of the target cells. In
control preparations, no attachment of lymphocytes to normal tissue cul-
ture cells occurred. The same phenomenon could be produced with lympho-
cytes from rat and human sources, with target cells from a wide variety of
cell lines. Cell lines spontaneously contaminated by mycoplasmas were ob-
served to attract lymphocytes, as might be expected, and the phenomenon
can only be studied with clean cell lines.
The mechanism provides an interesting way of bringing large numbers
of lymphocytes into permanent contact with the surface of target cells, in
a circumstance where the lymphocytes are not attracted to the scene be-
cause of any immunologic sense of mission, but because of the intrinsic
attraction of these cells to mycoplasmas. It raises the possibility that the
aggregation of lymphocytes, in the granulomatous lesions of mycoplasma
disease, may involve a similar mechanism.
REFERENCES
1. Kaklamanis, E. and Thomas, L.: Unpublished observations.
2. Thomas, L., Davidson, M. and McCluskey, R. T.: Studies of PPLO infection. I.
The production of cerebral polyarterisis by Mycoplasma gallisepticum in
turkeys; the neurotoxic property of the mycoplasmas. J. exp. Med., 1966,
123, 897-912.
3. Aleu, F. and Thomas, L.: Studies of PPLO infection. III. Electron microscopic
study of brain lesions caused by Mycoplasa neurolyticum toxin. J. exp. Med.,
1966,124, 1083-1088.
4. Thomas, L. Aleu, F., Bitensky, M. W., Davidson, M., and Gesner, B.: Studies of
PPLO infection. II. The neurotoxin of Mycoplasma neurolyticum. J. exp.
Med., 1966,124, 1067-1082.
447YALE JOURNAL OF BIOLOGY AND MEDICINE Volume 40, April, June, 1968
5. Thomas, L. and Bitensky, M. W.: Studies of PPLO infection. IV. The neurotoxi-
city of intact mycoplasmas, and their production of toxin in vivo and i'n vi-tro.
J. exp. Med., 1966,124, 1089-1098.
6. Gesner, B. and Thomas, L.: Sialic acid binding sites: Role in hemagglutination
by Mycoplasma gallisepticum. Science, 1965, 151, 590-591.
7. Thomas, L. and Bitensky, M. W.: Methaemoglobin formation by Mycoplasma
gallisepticum: the role of hydrogen peroxide. Nature, 1966, 210, 963-964.
8. Zucker-Franklin, D., Davidson, M., and Thomas, L.: The interaction of myco-
plasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils.
J. exp. Med., 1966,124, 521-532.
9. : The interaction of mycoplasmas with mammalian cells. II. Monocytes
and lymphocytes. J. exp. Med., 1966,124, 533-542.
448